This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rizzino, A. Search for Related Content PubMed PubMed Citation Articles by Rizzino, A.

Appearance of High Affinity Receptors for Type ß Transforming Growth Factor during Differentiation of Murine Embryonal Carcinoma Cells¹

Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska 68105

Recent studies have demonstrated that type ß transforming growth factor (TGF-ß) not only influences cell growth but also affects cell differentiation. In the present study, two different embryonal carcinoma (EC) cell lines and their differentiated cells were examined for the presence of TGF-ß receptors and for their responses to this factor. F9 and PC-13 EC cells bind little, if any, TGF-ß and do not appear to respond to TGF-ß in monolayer or soft agar cultures. Treatment of both EC cell lines with retinoic acid leads to the appearance of irreversibly differentiated cells that begin to exhibit receptors for TGF-ß by 48 h. After an additional 3–5 days, the differentiated cells express approximately 6000 high affinity receptors for TGF-ß, with an apparent dissociation constant of 45 pM. In contrast to the results observed with the parental EC cells, TGF-ß influences the growth of the differentiated cells cultured in both serum-free and serum-containing media. However, TGF-ß, alone or in combination with other growth factors, does not induce the differentiated cells to form colonies in soft agar. The possible relationship of these results to the roles of growth factors during early mammalian development is discussed.

¹ Supported by grants from the National Institute of Child Health and Human Development (HD 19837) and the National Cancer Institute (Laboratory Cancer Research Center Support Grant CA 36727).

² To whom requests for reprints should be addressed.

Received 3/17/87. Revised 5/19/87. Accepted 5/27/87.

This article has been cited by other articles:

				J. L. Kopp, P. J. Wilder, M. Desler, J.-H. Kim, J. Hou, T. Nowling, and A. Rizzino Unique and Selective Effects of Five Ets Family Members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the Promoter of the Type II Transforming Growth Factor-{beta} Receptor Gene J. Biol. Chem., May 7, 2004; 279(19): 19407 - 19420. [Abstract] [Full Text] [PDF]

				J.-H. Kim, P. J. Wilder, J. Hou, T. Nowling, and A. Rizzino Activation of the Murine Type II Transforming Growth Factor-beta Receptor Gene. UP-REGULATION AND FUNCTION OF THE TRANSCRIPTION FACTOR Elf-3/Ert/Esx/Ese-1 J. Biol. Chem., May 10, 2002; 277(20): 17520 - 17530. [Abstract] [Full Text] [PDF]

				Y.-H. Chen, D. Lavelle, J. DeSimone, S. Uddin, L. C. Platanias, and M. Hankewych Growth Inhibition of a Human Myeloma Cell Line by All-trans Retinoic Acid Is Not Mediated Through Downregulation of Interleukin-6 Receptors but Through Upregulation of p21WAF1 Blood, July 1, 1999; 94(1): 251 - 259. [Abstract] [Full Text] [PDF]

				D. Kelly, S.-J. Kim, and A. Rizzino Transcriptional Activation of the Type II Transforming Growth Factor-beta Receptor Gene upon Differentiation of Embryonal Carcinoma Cells J. Biol. Chem., August 14, 1998; 273(33): 21115 - 21124. [Abstract] [Full Text] [PDF]